Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - aujeszky's disease virus strain begonia - lyophilisate for suspension for injection - porcine - immunological - live vaccine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - suid herpesvirus 1 (live, attenuated), gi negative, tk negative - lyophilisate and solvent for suspension for injection - aujeszki virus - aujeszky's disease virus - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - suid herpesvirus 1 (live, attenuated), gi negative, tk negative - lyophilisate and solvent for suspension for injection - aujeszky's disease virus

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - suid herpesvirus 1 (live, attenuated), gi negative, tk negative - lyophilisate and solvent for suspension for injection - aujeszky's disease virus

European Union - English - EMA (European Medicines Agency)

intervet international bv - protein do (non-toxic deletion derivative of pasteurella multocida dermonecrotic toxin), inactivated bordetella bronchiseptica cells - immunologicals for suidae - pigs (gilts and sows) - for the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.

European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

European Union - English - EMA (European Medicines Agency)

intervet international bv - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae - pigs - for the active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce weight loss associated with porcine-circovirus-type-2 infection occurring during the fattening period.onset of immunity: 2 weeksduration of immunity: 22 weeks

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)